Scholars Central

Review articlePublished 24 May 2022

Pharmaceutical Biotechnology

Authors: Diana Norris

BioTechnology: An Indian Journal

Volume 18 · Issue 5 · Pages 51–53

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A biopharmaceutical, also known as a biological medical by-product, is a pharmaceutical drug by-product that is produced in, extracted from, or semi-synthesized from biological origin. They include vaccines, whole blood, blood products, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living drugs used in cell therapy, in addition to completely synthesized pharmaceuticals. Biologics are living cells or tissues that are made up of sugars, proteins, nucleic acids, or compound combinations of these materials. They (or their precursors or material) are introverts of living origin, such as humans, animals, plants, fungi, or microbes. They can be used in both human and animal treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in BioTechnology: An Indian Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBioTechnology: An Indian Journal
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Diana Norris”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels